# Imaging Acetadote Metabolism in Glioblastoma

> **NCT07387666** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Glioblastoma
- GBM

## Interventions

- **DRUG:** Acetadote

## Key facts

- **NCT ID:** NCT07387666
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07387666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07387666, "Imaging Acetadote Metabolism in Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07387666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*